Karyopharm Therapeutics Inc. Inventory
Karyopharm Therapeutics Inc. (KPTI) had Inventory of $3.99 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-08-13
- 2026-06-30: Inventory, Net $3.99M.
- 2026-03-31: Inventory, Net $3.60M.
- 2025-12-31: Inventory, Net $4.04M.
- 2025-09-30: Inventory, Net $3.97M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $3.99M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $3.60M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.04M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $3.97M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $4.99M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $4.77M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $4.74M 10-K · filed 2026-02-13 |
| 2024-09-30 | $4.67M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $3.48M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $2.77M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $3.04M 10-K · filed 2025-02-19 |
| 2023-09-30 | $3.10M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $3.67M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $3.83M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $4.22M 10-K · filed 2024-02-29 |
| 2022-09-30 | $4.25M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $3.47M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $3.87M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.11M 10-K · filed 2023-02-17 |
| 2021-09-30 | $3.94M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $3.90M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.11M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $2.64M 10-K · filed 2022-03-01 |
| 2020-09-30 | $2.01M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $1.65M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $970.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $346.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $100.00K 10-Q · filed 2019-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |